The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

Valued at a market capitalization of just $116,000, Zapata Computing (ZPTA) may appear tempting to investors. Its business ...

Adani Green Energy shares fell nearly 6% after reaching a day’s high, following a report that Sri Lanka cancelled a $440 ...

Buy Now, Pay Later (BNPL) firm Affirm Holdings (NASDAQ:AFRM) will avail $750 million in funding from Liberty Mutual ...

Fidus Investment Corp (NASDAQ:FDUS)'s stock has reached an unprecedented peak, marking an all-time high at $22.29. The ...

The president’s ultimatums and demands on allies and rivals suggest he will use America’s financial might as a cudgel ...

Mr. Bruni is a contributing Opinion writer. Ms. McLean is a contributing editor at Business Insider and an author of “The ...

Shriram Finance is estimated to see strong YoY growth in its net profit and net interest income (NII) in Q3FY25, while a healthy rise in disbursement is expected to drive steady AUM growth.

Wall Street is always musing about alternatives to Nvidia Corp. One analyst just suggested a big name that's not often in the conversation.